COYA
Income statement / Annual
Last year (2023), Coya Therapeutics, Inc.'s total revenue was $6.00 M,
and the percentage change from the previous year is not available.
In 2023, Coya Therapeutics, Inc.'s net income was -$7.99 M.
See Coya Therapeutics, Inc.�s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$6.00 M
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$27,361.00 |
$27,361.00 |
$16,133.00 |
$0.00 |
| Gross Profit |
$5.97 M |
-$27,361.00 |
-$16,133.00 |
$0.00 |
| Gross Profit Ratio |
1 |
0 |
0 |
0 |
| Research and Development
Expenses |
$5.50 M
|
$4.94 M
|
$2.54 M
|
$248,969.00
|
| General & Administrative
Expenses |
$7.83 M
|
$4.85 M
|
$2.31 M
|
$668,700.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$445,131.00
|
| Selling, General &
Administrative Expenses |
$7.83 M
|
$4.85 M
|
$2.31 M
|
$445,800.00
|
| Other Expenses |
$570,547.00 |
$27,361.00 |
$16,133.00 |
$0.00 |
| Operating Expenses |
$13.91 M |
$9.81 M |
$4.87 M |
$694,769.00 |
| Cost And Expenses |
$13.91 M |
$9.81 M |
$4.87 M |
$694,769.00 |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$58.46 |
| Interest Expense |
$0.00 |
$2.43 M |
$0.00 |
$38,976.00 |
| Depreciation &
Amortization |
$27,361.00
|
$27,361.00
|
$16,133.00
|
$704,654.00
|
| EBITDA |
-$7.90 M
|
-$12.22 M
|
-$4.85 M
|
$10,435.00
|
| EBITDA Ratio |
-1.32 |
0 |
0 |
0 |
| Operating Income Ratio
|
-1.32
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$639,365.00
|
-$2.43 M
|
-$21,482.00
|
-$38,426.00
|
| Income Before Tax |
-$7.26 M |
-$12.24 M |
-$4.89 M |
-$733,195.00 |
| Income Before Tax Ratio
|
-1.21
|
0
|
0
|
0
|
| Income Tax Expense |
$723,852.00 |
$2.43 M |
-$21,482.00 |
-$704.65 |
| Net Income |
-$7.99 M |
-$14.68 M |
-$4.87 M |
-$733,195.00 |
| Net Income Ratio |
-1.33 |
0 |
0 |
0 |
| EPS |
-0.79 |
-1.48 |
-0.5 |
-0.0757 |
| EPS Diluted |
-0.79 |
-1.48 |
-0.5 |
-0.0757 |
| Weighted Average Shares
Out |
$10.16 M
|
$9.95 M
|
$9.68 M
|
$9.68 M
|
| Weighted Average Shares
Out Diluted |
$10.16 M
|
$9.95 M
|
$9.68 M
|
$9.68 M
|
| Link |
|
|
|
|
